| 4 | Statement of changes in beneficial owner... | Syros Pharmaceuticals, Inc. | Donnelley Financial Solutions /fa | 11/20/2024 | |
| 4 | Statement of changes in beneficial owner... | Quirk Gerald E | Donnelley Financial Solutions /fa | 11/20/2024 | |
| 144 | Filing for proposed sale of securities u... | Syros Pharmaceuticals, Inc. | E Trade Financial Corp Llc Et Middle Office / Fa /fa | 11/19/2024 | |
| 144 | Filing for proposed sale of securities u... | Quirk Gerald E | E Trade Financial Corp Llc Et Middle Office / Fa /fa | 11/19/2024 | |
| 4 | Statement of changes in beneficial owner... | Syros Pharmaceuticals, Inc. | Donnelley Financial Solutions /fa | 10/02/2024 | |
| 4 | Statement of changes in beneficial owner... | Quirk Gerald E | Donnelley Financial Solutions /fa | 10/02/2024 | |
| 4 | Statement of changes in beneficial owner... | Syros Pharmaceuticals, Inc. | Donnelley Financial Solutions /fa | 04/02/2024 | |
| 4 | Statement of changes in beneficial owner... | Quirk Gerald E | Donnelley Financial Solutions /fa | 04/02/2024 | |
| 4 | Statement of changes in beneficial owner... | Quirk Gerald E | Donnelley Financial Solutions File16 /fa | 10/20/2023 | |
| 4 | Statement of changes in beneficial owner... | Syros Pharmaceuticals, Inc. | Donnelley Financial Solutions File16 /fa | 10/20/2023 | |
| Load More |